ELUT
HealthcareElutia Inc.
$1.08-0.07 (-5.65%)
Prev Close
$1.15
Open
$1.15
High
$1.19
Low
$1.08
Volume
101.1K
Market Cap
$50.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Elutia Inc. (ELUT) has been dominated by buying, with 15 insider purchases totaling $363.5K and 9 insider sales totaling $81.2K. The most recent insider transaction was by NEELS GUIDO J (director), who purchased $20.8K worth of shares on Feb 2, 2026. Elutia Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $50.0M.
Buys (12M)
15
$363.5K
Sells (12M)
9
$81.2K
Net Activity
Net Buyer
$282.3K
Active Insiders
9
last 12 mo
ELUT Price Chart
ELUT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026↗ | NEELS GUIDO J | director | Buy | 20,000 | $1.04 | $20.8K | 118,750 |
| Feb 2, 2026↗ | RAKIN KEVIN | director, 10 percent owner: | Buy | 70,000 | $1.06 | $74.2K | 196,120 |
| Jan 30, 2026↗ | NEELS GUIDO J | Director | Buy | 20,000 | $1.04 | $20.8K | 0 |
| Jan 30, 2026↗ | RAKIN KEVIN | Director | Buy | 70,000 | $1.06 | $74.2K | 0 |
| Jan 29, 2026↗ | NEELS GUIDO J | director | Buy | 30,000 | $1.06 | $31.8K | 98,750 |
| Jan 28, 2026↗ | NEELS GUIDO J | Director | Buy | 30,000 | $1.06 | $31.8K | 0 |
| Dec 17, 2025↗ | Colpman David | Director | Buy | 12,500 | $0.51 | $6.4K | 0 |
| Dec 17, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 60,000 | $0.53 | $31.8K | 0 |
| Dec 17, 2025↗ | Makes Brigid | Director | Buy | 25,000 | $0.52 | $13.0K | 0 |
| Dec 17, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Buy | 3,000 | $0.51 | $1.5K | 0 |
| Dec 17, 2025↗ | RAKIN KEVIN | Director | Buy | 50,000 | $0.52 | $26.0K | 0 |
| Dec 10, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,461 | $0.70 | $3.1K | 0 |
| Dec 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $0.70 | $6.8K | 0 |
| Dec 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,951 | $0.70 | $2.8K | 0 |
| Dec 1, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 10,000 | $0.66 | $6.6K | 0 |
| Nov 24, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Buy | 5,000 | $0.60 | $3.0K | 0 |
| Nov 17, 2025↗ | Colpman David | Director | Buy | 15,500 | $0.74 | $11.5K | 0 |
| Nov 13, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Buy | 13,500 | $0.75 | $10.1K | 0 |
| Sep 10, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 10,348 | $1.36 | $14.1K | 0 |
| Sep 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $1.36 | $13.1K | 0 |
| Sep 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,950 | $1.36 | $5.4K | 0 |
| Jun 10, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,461 | $1.99 | $8.9K | 0 |
| Jun 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $1.99 | $19.2K | 0 |
| Jun 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,951 | $1.99 | $7.9K | 0 |
| Mar 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 10,706 | $3.00 | $32.1K | 0 |
| Mar 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 4,613 | $3.00 | $13.8K | 0 |
| Mar 8, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 12,413 | $2.99 | $37.1K | 0 |
| Dec 10, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,461 | $4.29 | $19.1K | 318,744 |
| Dec 10, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 13,726 | $4.29 | $58.9K | 267,298 |
| Dec 10, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,950 | $4.29 | $16.9K | 68,399 |
| Sep 10, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 10,527 | $4.14 | $43.6K | 310,705 |
| Sep 10, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $4.14 | $40.0K | 253,941 |
| Sep 10, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,951 | $4.14 | $16.4K | 59,849 |
| Aug 12, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 17,840 | $2.84 | $50.7K | 289,983 |
| Aug 12, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 58,659 | $2.84 | $166.6K | 233,808 |
| Aug 12, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 15,800 | $2.84 | $44.9K | 51,300 |
| Jun 21, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 16,038 | $2.66 | $42.6K | 129,967 |
| Jun 10, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 8,920 | $3.47 | $31.0K | 152,743 |
| Jun 10, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 19,327 | $3.47 | $67.1K | 115,513 |
| Jun 10, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 7,900 | $3.47 | $27.4K | 17,100 |
| Mar 8, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 528 | $3.24 | $1.7K | 121,279 |
| Jun 21, 2023↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 7,772 | $2.41 | $18.7K | 62,710 |
| Mar 8, 2023↗ | Englese Thomas | CHIEF COMMERCIAL OFFICER | Sell | 289 | $4.30 | $1.2K | 17,917 |
| Dec 15, 2022↗ | Colpman David | Director | Buy | 3,098 | $3.90 | $12.1K | 3,098 |
| Dec 9, 2022↗ | Makes Brigid | Director | Buy | 2,000 | $3.65 | $7.3K | 2,000 |
| Dec 2, 2022↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 28,000 | $4.51 | $126.4K | 45,217 |
| Sep 8, 2022↗ | Edwards Peter G | GENERAL COUNSEL | Sell | 1,127 | $7.30 | $8.2K | 3,498 |
| Sep 8, 2022↗ | Englese Thomas | CHIEF COMMERCIAL OFFICER | Sell | 4,728 | $7.30 | $34.5K | 17,269 |
| Sep 8, 2022↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,798 | $7.30 | $35.0K | 17,217 |
| Sep 8, 2022↗ | Riebman Jerome | CHIEF MEDICAL OFFICER | Sell | 5,104 | $7.30 | $37.3K | 14,989 |
| Dec 14, 2021↗ | Englese Thomas | CHIEF COMMERCIAL OFFICER | Buy | 4,580 | $6.10 | $27.9K | 5,088 |
| May 10, 2021↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 2,300 | $11.08 | $25.5K | 2,300 |
| May 7, 2021↗ | LLOYD RONALD K. | PRESIDENT AND CEO | Buy | 8,565 | $11.75 | $100.6K | 23,151 |
ELUT Insider Buying Activity
The following table shows recent insider purchases of Elutia Inc. (ELUT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026↗ | NEELS GUIDO J | director | Buy | 20,000 | $1.04 | $20.8K | 118,750 |
| Feb 2, 2026↗ | RAKIN KEVIN | director, 10 percent owner: | Buy | 70,000 | $1.06 | $74.2K | 196,120 |
| Jan 30, 2026↗ | NEELS GUIDO J | Director | Buy | 20,000 | $1.04 | $20.8K | 0 |
| Jan 30, 2026↗ | RAKIN KEVIN | Director | Buy | 70,000 | $1.06 | $74.2K | 0 |
| Jan 29, 2026↗ | NEELS GUIDO J | director | Buy | 30,000 | $1.06 | $31.8K | 98,750 |
| Jan 28, 2026↗ | NEELS GUIDO J | Director | Buy | 30,000 | $1.06 | $31.8K | 0 |
| Dec 17, 2025↗ | Colpman David | Director | Buy | 12,500 | $0.51 | $6.4K | 0 |
| Dec 17, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 60,000 | $0.53 | $31.8K | 0 |
| Dec 17, 2025↗ | Makes Brigid | Director | Buy | 25,000 | $0.52 | $13.0K | 0 |
| Dec 17, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Buy | 3,000 | $0.51 | $1.5K | 0 |
| Dec 17, 2025↗ | RAKIN KEVIN | Director | Buy | 50,000 | $0.52 | $26.0K | 0 |
| Dec 1, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 10,000 | $0.66 | $6.6K | 0 |
| Nov 24, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Buy | 5,000 | $0.60 | $3.0K | 0 |
| Nov 17, 2025↗ | Colpman David | Director | Buy | 15,500 | $0.74 | $11.5K | 0 |
| Nov 13, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Buy | 13,500 | $0.75 | $10.1K | 0 |
| Dec 15, 2022↗ | Colpman David | Director | Buy | 3,098 | $3.90 | $12.1K | 3,098 |
| Dec 9, 2022↗ | Makes Brigid | Director | Buy | 2,000 | $3.65 | $7.3K | 2,000 |
| Dec 2, 2022↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 28,000 | $4.51 | $126.4K | 45,217 |
| Dec 14, 2021↗ | Englese Thomas | CHIEF COMMERCIAL OFFICER | Buy | 4,580 | $6.10 | $27.9K | 5,088 |
| May 10, 2021↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Buy | 2,300 | $11.08 | $25.5K | 2,300 |
| May 7, 2021↗ | LLOYD RONALD K. | PRESIDENT AND CEO | Buy | 8,565 | $11.75 | $100.6K | 23,151 |
ELUT Insider Selling Activity
The following table shows recent insider sales of Elutia Inc. (ELUT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,461 | $0.70 | $3.1K | 0 |
| Dec 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $0.70 | $6.8K | 0 |
| Dec 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,951 | $0.70 | $2.8K | 0 |
| Sep 10, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 10,348 | $1.36 | $14.1K | 0 |
| Sep 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $1.36 | $13.1K | 0 |
| Sep 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,950 | $1.36 | $5.4K | 0 |
| Jun 10, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,461 | $1.99 | $8.9K | 0 |
| Jun 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $1.99 | $19.2K | 0 |
| Jun 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,951 | $1.99 | $7.9K | 0 |
| Mar 10, 2025↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 10,706 | $3.00 | $32.1K | 0 |
| Mar 10, 2025↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 4,613 | $3.00 | $13.8K | 0 |
| Mar 8, 2025↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 12,413 | $2.99 | $37.1K | 0 |
| Dec 10, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,461 | $4.29 | $19.1K | 318,744 |
| Dec 10, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 13,726 | $4.29 | $58.9K | 267,298 |
| Dec 10, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,950 | $4.29 | $16.9K | 68,399 |
| Sep 10, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 10,527 | $4.14 | $43.6K | 310,705 |
| Sep 10, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 9,664 | $4.14 | $40.0K | 253,941 |
| Sep 10, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 3,951 | $4.14 | $16.4K | 59,849 |
| Aug 12, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 17,840 | $2.84 | $50.7K | 289,983 |
| Aug 12, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 58,659 | $2.84 | $166.6K | 233,808 |
| Aug 12, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 15,800 | $2.84 | $44.9K | 51,300 |
| Jun 21, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 16,038 | $2.66 | $42.6K | 129,967 |
| Jun 10, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 8,920 | $3.47 | $31.0K | 152,743 |
| Jun 10, 2024↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 19,327 | $3.47 | $67.1K | 115,513 |
| Jun 10, 2024↗ | Williams Michelle LeRoux | CHIEF SCIENTIFIC OFFICER | Sell | 7,900 | $3.47 | $27.4K | 17,100 |
| Mar 8, 2024↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 528 | $3.24 | $1.7K | 121,279 |
| Jun 21, 2023↗ | Mills C Randal | PRESIDENT AND CEO | Sell | 7,772 | $2.41 | $18.7K | 62,710 |
| Mar 8, 2023↗ | Englese Thomas | CHIEF COMMERCIAL OFFICER | Sell | 289 | $4.30 | $1.2K | 17,917 |
| Sep 8, 2022↗ | Edwards Peter G | GENERAL COUNSEL | Sell | 1,127 | $7.30 | $8.2K | 3,498 |
| Sep 8, 2022↗ | Englese Thomas | CHIEF COMMERCIAL OFFICER | Sell | 4,728 | $7.30 | $34.5K | 17,269 |
| Sep 8, 2022↗ | Ferguson Matthew | CHIEF FINANCIAL OFFICER | Sell | 4,798 | $7.30 | $35.0K | 17,217 |
| Sep 8, 2022↗ | Riebman Jerome | CHIEF MEDICAL OFFICER | Sell | 5,104 | $7.30 | $37.3K | 14,989 |
ELUT Insiders
Similar Stocks to ELUT
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B